Cargando…
Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report
Lithium-induced nephrogenic diabetes insipidus (Li-NDI) is a rare and difficult-to-treat condition. A study in mice and two recent papers describe the use of acetazolamide in Li-NDI in 7 patients (a case report and a 6 patient series). We describe the case of a 63-year-old woman with bipolar disorde...
Autores principales: | Macau, Ricardo A, da Silva, Tiago Nunes, Silva, Joana Rego, Ferreira, Ana Gonçalves, Bravo, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820740/ https://www.ncbi.nlm.nih.gov/pubmed/29479446 http://dx.doi.org/10.1530/EDM-17-0154 |
Ejemplares similares
-
Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis
por: Schwetz, Verena, et al.
Publicado: (2015) -
Arginine-vasopressin infusion in a child with cranial diabetes insipidus during hyperhydration therapy with chemotherapy: a therapeutic challenge
por: Devaraja, Janani, et al.
Publicado: (2021) -
Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus
por: Sim, Jae H., et al.
Publicado: (2014) -
Tamoxifen Decreases Lithium-Induced Natriuresis in Rats With Nephrogenic Diabetes Insipidus
por: Tingskov, Stine Julie, et al.
Publicado: (2018) -
A Rare Case of Lithium-induced Partial Nephrogenic Diabetes Insipidus
por: Rauf, Abdul, et al.
Publicado: (2020)